Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Deceased-donor acute kidney injury is not associated with kidney allograft failure.

Hall IE, Akalin E, Bromberg JS, Doshi MD, Greene T, Harhay MN, Jia Y, Mansour SG, Mohan S, Muthukumar T, Reese PP, Schröppel B, Singh P, Thiessen-Philbrook HR, Weng FL, Parikh CR.

Kidney Int. 2019 Jan;95(1):199-209. doi: 10.1016/j.kint.2018.08.047. Epub 2018 Nov 20.

PMID:
30470437
2.

Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function.

Schröppel B, Heeger PS, Thiessen-Philbrook H, Hall IE, Doshi MD, Weng FL, Reese PP, Parikh CR.

Transplantation. 2019 Jan;103(1):e29-e35. doi: 10.1097/TP.0000000000002494.

PMID:
30451738
3.

Reliability of deceased-donor procurement kidney biopsy images uploaded in United Network for Organ Sharing.

Mansour SG, Hall IE, Reese PP, Jia Y, Thiessen-Philbrook H, Moeckel G, Weng FL, Revelo MP, Khalighi MA, Trivedi A, Doshi MD, Schröppel B, Parikh CR.

Clin Transplant. 2018 Dec;32(12):e13441. doi: 10.1111/ctr.13441. Epub 2018 Dec 6.

PMID:
30387908
4.

Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival.

Hall IE, Parikh CR, Schröppel B, Weng FL, Jia Y, Thiessen-Philbrook H, Reese PP, Doshi MD.

Transplant Direct. 2018 Jul 16;4(8):e373. doi: 10.1097/TXD.0000000000000816. eCollection 2018 Aug.

5.

APOL1 Genotype and Renal Function of Black Living Donors.

Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, Kopp JB.

J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.

6.

Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.

Moledina DG, Hall IE, Thiessen-Philbrook H, Reese PP, Weng FL, Schröppel B, Doshi MD, Wilson FP, Coca SG, Parikh CR.

Am J Kidney Dis. 2017 Dec;70(6):807-816. doi: 10.1053/j.ajkd.2017.06.031. Epub 2017 Aug 24.

7.

Associations between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.

Mansour SG, Puthumana J, Reese PP, Hall IE, Doshi MD, Weng FL, Schröppel B, Thiessen-Philbrook H, Bimali M, Parikh CR.

Kidney Int Rep. 2017 Jul;2(4):749-758. doi: 10.1016/j.ekir.2017.03.007. Epub 2017 Mar 31.

8.

Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.

Hall IE, Reese PP, Doshi MD, Weng FL, Schröppel B, Asch WS, Ficek J, Thiessen-Philbrook H, Parikh CR.

Transplantation. 2017 Aug;101(8):1913-1923. doi: 10.1097/TP.0000000000001409.

9.

Utility of Applying Quality Assessment Tools for Kidneys With KDPI ≥80.

Doshi MD, Reese PP, Hall IE, Schröppel B, Ficek J, Formica RN, Weng FL, Hasz RD, Thiessen-Philbrook H, Parikh CR.

Transplantation. 2017 Jun;101(6):1125-1133. doi: 10.1097/TP.0000000000001388.

10.

YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation.

Puthumana J, Hall IE, Reese PP, Schröppel B, Weng FL, Thiessen-Philbrook H, Doshi MD, Rao V, Lee CG, Elias JA, Cantley LG, Parikh CR.

J Am Soc Nephrol. 2017 Feb;28(2):661-670. doi: 10.1681/ASN.2016010091. Epub 2016 Jul 22.

11.

Associations of Perfusate Biomarkers and Pump Parameters With Delayed Graft Function and Deceased Donor Kidney Allograft Function.

Parikh CR, Hall IE, Bhangoo RS, Ficek J, Abt PL, Thiessen-Philbrook H, Lin H, Bimali M, Murray PT, Rao V, Schröppel B, Doshi MD, Weng FL, Reese PP.

Am J Transplant. 2016 May;16(5):1526-39. doi: 10.1111/ajt.13655. Epub 2016 Feb 17.

12.

Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.

Potluri VS, Parikh CR, Hall IE, Ficek J, Doshi MD, Butrymowicz I, Weng FL, Schröppel B, Thiessen-Philbrook H, Reese PP.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):324-31. doi: 10.2215/CJN.06950615. Epub 2015 Dec 14.

13.

Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.

Bhat ZY, Cadnapaphornchai P, Ginsburg K, Sivagnanam M, Chopra S, Treadway CK, Lin HS, Yoo G, Sukari A, Doshi MD.

PLoS One. 2015 Nov 10;10(11):e0142225. doi: 10.1371/journal.pone.0142225. eCollection 2015.

14.

Associations between Deceased-Donor Urine Injury Biomarkers and Kidney Transplant Outcomes.

Reese PP, Hall IE, Weng FL, Schröppel B, Doshi MD, Hasz RD, Thiessen-Philbrook H, Ficek J, Rao V, Murray P, Lin H, Parikh CR.

J Am Soc Nephrol. 2016 May;27(5):1534-43. doi: 10.1681/ASN.2015040345. Epub 2015 Sep 15.

15.

Associations of deceased donor kidney injury with kidney discard and function after transplantation.

Hall IE, Schröppel B, Doshi MD, Ficek J, Weng FL, Hasz RD, Thiessen-Philbrook H, Reese PP, Parikh CR.

Am J Transplant. 2015 Jun;15(6):1623-31. doi: 10.1111/ajt.13144. Epub 2015 Mar 11.

16.

Glutathione S-transferase iso-enzymes in perfusate from pumped kidneys are associated with delayed graft function.

Hall IE, Bhangoo RS, Reese PP, Doshi MD, Weng FL, Hong K, Lin H, Han G, Hasz RD, Goldstein MJ, Schröppel B, Parikh CR.

Am J Transplant. 2014 Apr;14(4):886-96. doi: 10.1111/ajt.12635. Epub 2014 Feb 24.

17.

Preimplant histologic acute tubular necrosis and allograft outcomes.

Hall IE, Reese PP, Weng FL, Schröppel B, Doshi MD, Hasz RD, Reitsma W, Goldstein MJ, Hong K, Parikh CR.

Clin J Am Soc Nephrol. 2014 Mar;9(3):573-82. doi: 10.2215/CJN.08270813. Epub 2014 Feb 20.

18.

Not seeing does not equal absent-acceptance of live kidney donors with metabolic syndrome.

Doshi MD.

Am J Transplant. 2013 Sep;13(9):2241-2. doi: 10.1111/ajt.12371. Epub 2013 Aug 5. No abstract available.

19.

Is delayed graft function causally associated with long-term outcomes after kidney transplantation? Instrumental variable analysis.

Butala NM, Reese PP, Doshi MD, Parikh CR.

Transplantation. 2013 Apr 27;95(8):1008-14. doi: 10.1097/TP.0b013e3182855544.

20.

Medical outcomes in African American live kidney donors: a matched cohort study.

Doshi MD, Goggins MO, Li L, Garg AX.

Am J Transplant. 2013 Jan;13(1):111-8. doi: 10.1111/j.1600-6143.2012.04303.x. Epub 2012 Oct 24.

21.

Association between peritransplant kidney injury biomarkers and 1-year allograft outcomes.

Hall IE, Doshi MD, Reese PP, Marcus RJ, Thiessen-Philbrook H, Parikh CR.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1224-33. Epub 2012 Jun 21.

22.

Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation.

Hall IE, Koyner JL, Doshi MD, Marcus RJ, Parikh CR.

Am J Nephrol. 2011;33(5):407-13. doi: 10.1159/000326753. Epub 2011 Apr 15.

23.

A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation.

Hall IE, Doshi MD, Poggio ED, Parikh CR.

Transplantation. 2011 Jan 15;91(1):48-56. doi: 10.1097/TP.0b013e3181fc4b3a.

PMID:
21441853
24.

Recipient risk factors associated with delayed graft function: a paired kidney analysis.

Doshi MD, Garg N, Reese PP, Parikh CR.

Transplantation. 2011 Mar 27;91(6):666-71. doi: 10.1097/TP.0b013e318209f22b.

PMID:
21317839
25.

Different patterns of cancer incidence among African American and Caucasian renal allograft recipients.

Gruber SA, Singh A, Mehta K, Morawski K, West MS, Doshi MD.

Surgery. 2010 Oct;148(4):661-5; discussion 665-6. doi: 10.1016/j.surg.2010.07.016. Epub 2010 Aug 17.

PMID:
20719349
26.

Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits.

Gruber SA, Doshi MD.

Transplantation. 2010 May 15;89(9):1161-2. doi: 10.1097/TP.0b013e3181d1f238. No abstract available.

PMID:
20440195
27.

Health insurance status of US living kidney donors.

Gibney EM, Doshi MD, Hartmann EL, Parikh CR, Garg AX.

Clin J Am Soc Nephrol. 2010 May;5(5):912-6. doi: 10.2215/CJN.07121009. Epub 2010 Apr 22.

28.

Does donor race still make a difference in deceased-donor African-American renal allograft recipients?

Brown KL, Doshi MD, Singh A, Mehta K, Morawski K, Cincotta E, West MS, Gruber SA.

Am J Surg. 2010 Mar;199(3):305-9; discussion 309. doi: 10.1016/j.amjsurg.2009.08.025.

PMID:
20226900
29.

Equivalent outcomes with primary and retransplantation in African-American deceased-donor renal allograft recipients.

Gruber SA, Brown KL, El-Amm JM, Singh A, Mehta K, Morawski K, Cincotta E, Nehlsen-Cannarella S, Losanoff JE, West MS, Doshi MD.

Surgery. 2009 Oct;146(4):646-52; discussion 652-3. doi: 10.1016/j.surg.2009.05.020.

PMID:
19789023
30.

Outcome predictors in African-American deceased-donor renal allograft recipients.

Brown KL, El-Amm JM, Doshi MD, Singh A, Cincotta E, Morawski K, Losanoff JE, West MS, Gruber SA.

Clin Transplant. 2009 Aug-Sep;23(4):454-61. doi: 10.1111/j.1399-0012.2008.00917.x. Epub 2008 Dec 22.

PMID:
19191806
31.

Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates.

Gruber SA, Doshi MD, Cincotta E, Brown KL, Singh A, Morawski K, Alangaden G, Chandrasekar P, Losanoff JE, West MS, El-Amm JM.

Transplantation. 2008 Jul 27;86(2):269-74. doi: 10.1097/TP.0b013e318177884e.

PMID:
18645490
32.

Steroid avoidance in African Americans: does inadequate induction lead to increased early rejection and long-term graft injury?

Doshi MD, El-Amm JM, Gruber SA.

Am J Transplant. 2008 Aug;8(8):1759-60; author reply 1761-2. doi: 10.1111/j.1600-6143.2008.02292.x. Epub 2008 Jun 28. No abstract available.

33.

Intermediate-term outcomes of hepatitis C-positive compared with hepatitis C-negative deceased-donor renal allograft recipients.

Brown KL, El-Amm JM, Doshi MD, Singh A, Morawski K, Cincotta E, Siddiqui F, Losanoff JE, West MS, Gruber SA.

Am J Surg. 2008 Mar;195(3):298-302; discussion 302-3. doi: 10.1016/j.amjsurg.2007.12.005.

PMID:
18190891
34.

Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy.

Zeng X, El-Amm JM, Doshi MD, Singh A, Morawski K, Cincotta E, Losanoff JE, West MS, Gruber SA.

Surgery. 2007 Oct;142(4):538-44; discussion 544-5.

PMID:
17950346
35.

Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients.

Haririan A, Morawski K, West MS, El-Amm JM, Doshi MD, Cincotta E, Alangaden GJ, Chandrasekar P, Gruber SA.

Clin Transplant. 2007 Jul-Aug;21(4):466-71.

PMID:
17645705
36.

Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation.

El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA.

Transplantation. 2007 Mar 15;83(5):546-9.

PMID:
17353771
37.

Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death.

Doshi MD, Hunsicker LG.

Am J Transplant. 2007 Jan;7(1):122-9. Epub 2006 Oct 25.

38.

Short-term experience with early steroid withdrawal in African-American renal transplant recipients.

Haririan A, Sillix DH, Morawski K, El-Amm JM, Garnick J, Doshi MD, West MS, Gruber SA.

Am J Transplant. 2006 Oct;6(10):2396-402. Epub 2006 Jul 26.

Supplemental Content

Loading ...
Support Center